The treatment of knee cartilage lesions: state of the art.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
31 08 2022
Historique:
received: 05 05 2021
accepted: 11 01 2022
entrez: 31 8 2022
pubmed: 1 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

The management and repair of knee cartilage lesions currently represents a challenge for the orthopaedic surgeon. Identifiable causes are the characteristics of the involved tissues themselves and the presence of poor vascularization, which is responsible for overall reduced repair capacity. The literature reports three types of cartilage lesions' treatment modalities: chondroprotection, chondroreparation and chondrogeneration. The preference for one or the other therapeutic option depends on the pattern of the lesion and the clinical conditions of the patient. Each treatment technique is distinguished by the quality of the restorative tissue that is generated. In particular, the chondrorigeneration represents the last frontier of regenerative medicine, as it aims at the complete restoration of natural cartilage. However, the most recent literature documents good results only in the short and medium terms. In recent years the optimization of chondroregeneration outcomes is based on the modification of the scaffolds and the search for new chondrocyte sources, in order to guarantee satisfactory long-term results.

Identifiants

pubmed: 36043984
doi: 10.23750/abm.v93i4.11740
pmc: PMC9534246
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2022099

Références

Joints. 2016 Jun 13;4(1):47-51
pubmed: 27386447
Cartilage. 2021 Jan;12(1):76-92
pubmed: 30373384
Eur Cell Mater. 2013 Jun 28;25:299-316; discussion 314-6
pubmed: 23813020
Am J Sports Med. 2018 Mar;46(4):826-831
pubmed: 29253350
J Bone Joint Surg Br. 2012 Apr;94(4):504-9
pubmed: 22434467
Int J Surg. 2019 Aug;68:56-62
pubmed: 31220632
Orthop J Sports Med. 2015 Apr 27;3(5):2325967115581163
pubmed: 26674652
Sports Health. 2016 Mar-Apr;8(2):153-60
pubmed: 26502188
J Bone Joint Surg Am. 2003;85-A Suppl 2:25-32
pubmed: 12721342
Curr Stem Cell Res Ther. 2018;13(7):583-590
pubmed: 28721819
Knee Surg Sports Traumatol Arthrosc. 2016 May;24(5):1617-26
pubmed: 25661676
Cell Tissue Bank. 2018 Mar;19(1):35-46
pubmed: 28815373
Acta Biochim Pol. 2015;62(3):329-37
pubmed: 26200199
Am J Transl Res. 2019 Oct 15;11(10):6650-6659
pubmed: 31737215
J Clin Med. 2019 Jun 01;8(6):
pubmed: 31159439
Arthroscopy. 2019 Oct;35(10):2771-2773
pubmed: 31604490
Am J Sports Med. 2018 Mar;46(4):995-999
pubmed: 28423287
Am J Orthop (Belle Mead NJ). 2000 Feb;29(2):80-8; discussion 88-9
pubmed: 10695858
Clin Orthop Relat Res. 2001 Oct;(391 Suppl):S306-17
pubmed: 11603714
Knee. 2015 Jan;22(1):30-5
pubmed: 25480381
Cell Stem Cell. 2016 May 5;18(5):573-86
pubmed: 27152442
Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74
pubmed: 22563589
Sports Health. 2009 Nov;1(6):461-8
pubmed: 23015907
Joints. 2016 Aug 18;4(2):87-93
pubmed: 27602348
Ann Transl Med. 2016 Dec;4(24):540
pubmed: 28149901
Acta Biomed. 2017 Oct 18;88(4S):5-10
pubmed: 29083347
Ther Adv Musculoskelet Dis. 2017 Sep;9(9):231-246
pubmed: 28932293
Oncol Lett. 2018 May;15(5):7021-7027
pubmed: 29731871
JBJS Essent Surg Tech. 2019 Oct 23;9(4):
pubmed: 32051778
Am J Sports Med. 2014 Jul;42(7):1618-27
pubmed: 24817007
Cartilage. 2017 Oct;8(4):341-364
pubmed: 28317389
Arthrosc Tech. 2020 May 14;9(6):e755-e759
pubmed: 32577348
Bioengineering (Basel). 2019 Mar 13;6(1):
pubmed: 30871236
Int J Mol Sci. 2018 Aug 11;19(8):
pubmed: 30103493
Dis Model Mech. 2018 Jun 19;11(6):
pubmed: 29728409
Int Orthop. 2013 Nov;37(11):2139-45
pubmed: 23917852
World J Orthop. 2014 Nov 18;5(5):677-84
pubmed: 25405097
Acta Orthop Traumatol Turc. 2016 Dec;50(6):635-638
pubmed: 27817976

Auteurs

Giuseppe Talesa (G)

a:1:{s:5:"en_US";s:25:"Ortopedia e Traumatologia";}. talesa.giuseppe@libero.it.

Francesco Manfreda (F)

. francesco.manfreda@libero.it.

Valerio Pace (V)

. valeriopace@doctors.org.uk.

Paolo Ceccarini (P)

. drpaoloceccarini@gmail.com.

Pierluigi Antinolfi (P)

. pantinolfi@gmail.com.

Giuseppe Rinonapoli (G)

. grinonapoli@yahoo.it.

Auro Caraffa (A)

. auro.caraffa@unipg.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH